4Dmedical (Australia) Insiders

4Dmedical Management Team Effectiveness

The company has return on total asset (ROA) of (0.2695) % which means that it has lost $0.2695 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5054) %, meaning that it generated substantial loss on money invested by shareholders. 4Dmedical's management efficiency ratios could be used to measure how well 4Dmedical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, 4Dmedical's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 126 M in 2024, whereas Non Current Liabilities Other is likely to drop slightly above 12.7 M in 2024. Common Stock Shares Outstanding is likely to drop to about 209.4 M in 2024. Net Loss is likely to gain to about (26.9 M) in 2024

4Dmedical Workforce Comparison

4Dmedical Benchmark Summation

4Dmedical Notable Stakeholders

The success or failure of an entity such as 4Dmedical often depends on how effective the management is. 4Dmedical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of 4Dmedical management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the 4Dmedical management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in 4Dmedical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of 4Dmedical. Check 4Dmedical's Beneish M Score to see the likelihood of 4Dmedical's management manipulating its earnings.

When running 4Dmedical's price analysis, check to measure 4Dmedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4Dmedical is operating at the current time. Most of 4Dmedical's value examination focuses on studying past and present price action to predict the probability of 4Dmedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4Dmedical's price. Additionally, you may evaluate how the addition of 4Dmedical to your portfolios can decrease your overall portfolio volatility.